Rimonabant
Obese Patients With or Without Comorbidities (RIO-North America)
Sanofi · Phase 3 · Completed · Enrollment 3045
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Registry arm not named | Obesity or overweight | n/r | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Rimonabant
Sanofi · Phase 3 · Completed · Enrollment 3045
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Registry arm not named | Obesity or overweight | n/r | n/r | n/r | n/r |